| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |